|
Written by Staff and Wire Reports
|
|
Tuesday, 20 March 2012 03:46 |
If you haven't become familiar with NovaBay Pharmaceuticals (AMEX:NBY), now may be a good time to start. The Emeryville, California based firm has announced several key developments and catalysts which could affect price action.
|
|
Read more...
|
|
Written by Staff and Wire Reports
|
|
Monday, 19 March 2012 19:12 |
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 19, 2012.
|
|
Read more...
|
|
Written by M.E.Garza
|
|
Monday, 19 March 2012 14:10 |
 Shares of Ampio Pharmaceuticals (NASDAQ:AMPE) rocketed over 60% to a high of $4.58 on Monday after the company decided to end a study for its ophthalmology drug Optina™ ahead of schedule due to positive preliminary results and there are plenty of hints that the bulls may not be done here.
|
|
Read more...
|
|
Written by Staff and Wire Reports
|
|
Monday, 19 March 2012 10:47 |
{nfg} With California voters set to vote in June on a proposition (Prop 29) that would generate more than $700 million a year for cancer research and anti-smoking efforts through a new $1 a pack tax on cigarettes,
|
|
Read more...
|
|
Written by Beth McElhenny & Philip Tate
|
|
Friday, 16 March 2012 00:00 |
|
Positron (OTC:POSC.OB) shares still look undervalued following news of the acquisition of Manhattan Isotopes Technologies (MIT). MIT is a game changer for the company.
|
|
Read more...
|
|
Written by Staff and Wire Reports
|
|
Thursday, 15 March 2012 19:22 |
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 15, 2012.
|
|
Read more...
|
|
Written by Staff and Wire Reports
|
|
Wednesday, 14 March 2012 20:07 |
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 14, 2012.
|
|
Read more...
|
|
Written by By George S. Mack of The Life Sciences Report
|
|
Wednesday, 14 March 2012 00:00 |
Medical technology has been stalled in a quagmire of regulation, lowered usage and a more tight-fisted health insurance environment, but Analyst and Managing Director Joanne Wuensch of BMO Capital Markets has identified a few ground-breaking technologies that will drive increasing cash flows in particular companies.
|
|
Read more...
|
|
Written by Staff and Wire Reports
|
|
Tuesday, 13 March 2012 20:04 |
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 13, 2012.
|
|
Read more...
|
|
Written by Brian Wilson
|
|
Tuesday, 13 March 2012 00:00 |
Affymax (NASDAQ:AFFY) is a pharmaceutical company worth $393 million that is in the process of developing the drug Peginesatide, which is an investigational drug that treats anemia associated with chronic kidney disease (CKD).
|
|
Read more...
|